Drug Shortage Report for QVAR
Report ID | 177248 |
Drug Identification Number | 02242030 |
Brand name | QVAR |
Common or Proper name | QVAR |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | BECLOMETHASONE DIPROPIONATE |
Strength(s) | 100MCG |
Dosage form(s) | METERED-DOSE AEROSOL |
Route of administration | INHALATION INHALATION |
Packaging size | n/a |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-03-06 |
Actual start date | |
Estimated end date | 2023-03-24 |
Actual end date | 2023-03-21 |
Shortage status | Resolved |
Updated date | 2023-03-23 |
Company comments | delay in production |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-03-23 | French | Compare |
v9 | 2023-03-23 | English | Compare |
v8 | 2023-03-07 | French | Compare |
v7 | 2023-03-03 | French | Compare |
v6 | 2023-03-03 | English | Compare |
v5 | 2023-02-18 | English | Compare |
v4 | 2023-02-08 | French | Compare |
v3 | 2023-02-08 | English | Compare |
v2 | 2022-12-07 | French | Compare |
v1 | 2022-12-07 | English | Compare |
Showing 1 to 10 of 10